ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
The Adipose-Sympathetic Nerve Crosstalk: FSTL1 as an Adipocyte-Derived Neurotrophic Factor for WAT Browning.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Follistatin-like 1 (FSTL1) has been considered a vital adipokine. Several lines of evidence have shown that FSTL1 is essential for white adipose tissue (WAT) adipogenesis, brown adipose tissue involution, and thermogenesis. However, the roles of FSTL1 in WAT browning and its underlying mechanisms are not fully understood. Our data show that FSTL1 overexpression induces WAT browning, enhances energy metabolism, and promotes glucose uptake in male mice at ambient room temperature. Overexpression of FSTL1 specifically in WAT prevents metabolic dysfunction in mice with diet-induced obesity. Mice with FSTL1 deficiency exhibit cold intolerance and are prone to obesity. FSTL1 cannot directly induce adipocyte browning in vitro. FSTL1 promotes sympathetic innervation both in vivo and in vitro. Furthermore, sympathetic denervation in adipose tissue abrogates FSTL1-induced browning, enhancement of energy metabolism, and regional glucose uptake. Notably, FSTL1 is endocytosed by sympathetic neurons primarily via tropomyosin-related kinase B (TrkB) in vitro. Blocking TrkB suppresses WAT browning and sympathetic innervation induced by FSTL1 overexpression in adipose tissue. Our findings shed new light on the role of FSTL1 in WAT browning and identify FSTL1 as an adipose-derived 'neurotrophic factor' adipokine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.